Display options
Share it on

Cancer Manag Res. 2019 Feb 15;11:1559-1567. doi: 10.2147/CMAR.S189025. eCollection 2019.

Identification of chromosomal abnormalities and genomic features in near-triploidy/tetraploidy-acute leukemia by fluorescence in situ hybridization.

Cancer management and research

Ruqing Yang, Minghua Jiang, Junzhao Zhao, Hui Chen, Jian Gong, Yaying You, Laiyue Song, Zhen Li, Qian Li

Affiliations

  1. Reproductive Medicine Center, Department of Gynaecology and Obstetrics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
  2. Department of Clinical Laboratory, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China, [email protected].
  3. The Second Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
  4. Department of Traditional Chinese Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Key Laboratory for Major Obstetric Diseases of Guangdong Province, Guangzhou, Guangdong 510150, China, [email protected].

PMID: 30863166 PMCID: PMC6388942 DOI: 10.2147/CMAR.S189025

Abstract

BACKGROUND: Near-triploidy/tetraploidy is rarely found in acute leukemia. Only limited data are available to characterize this condition, and it remains largely unknown.

PATIENTS AND METHODS: In our study, we performed karyotype analysis on 1,031 patients diagnosed with acute leukemia from 2006 to 2018. A total of 10 patients of near-triploidy/tetraploidy karyotype were enrolled. Two cases of near-triploidy (66-79 chromosomes) and eight cases of near-tetraploidy (84-100 chromosomes) were identified. Bone marrow samples of these 10 patients were analyzed by fluorescence in situ hybridization with 19 commercially available probes that detected a small portion of gene alterations and large regions of chromosome amplifications.

RESULTS: Of the six patients with acute myelocytic leukemia, we detected three cases of double t(8;21)(q22;q22) that have not been previously reported, and one of them demonstrated ins(21;8) (q22;q24q22). We also describe a novel pediatric case carrying double t(15;17)(q22;q21) and receiving targeted treatment with all-trans retinoic acid therapy. To date, this case has responded well to the regimen and has shown continuous complete remission. All patients received chemotherapy. One of them received allogeneic hematopoietic stem cell transplant (HSCT) and survived for 22 months. Eight of the 10 patients died, and the median overall survival was 11 months.

CONCLUSION: Using fluorescence in situ hybridization, we identified the distinct complex karyotype of near-triploidy/tetraploidy and provided further prognostic information. Tetraploidy acute promyelocytic leukemia had favorable prognosis; thus, HSCT was not necessary. The case of insertion t(21;8)(q22;q24q22) in tetraploidy responded poorly to chemotherapy and achieved molecular remission with difficultly. Data from patients in this group indicated that near-triploidy/tetraploidy acute leukemia has poor prognosis and new therapy is urgently needed.

Keywords: acute leukemia; fluorescence in situ hybridization; gene; near-triploidy; tetraploidy karyotype

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

  1. Int J Hematol. 2000 Jun;71(4):359-65 - PubMed
  2. Int J Hematol. 2001 Oct;74(3):316-21 - PubMed
  3. Cancer Genet Cytogenet. 2003 Sep;145(2):169-71 - PubMed
  4. Blood. 1992 Jul 15;80(2):492-7 - PubMed
  5. Cancer Genet Cytogenet. 2003 Dec;147(2):134-9 - PubMed
  6. Blood. 2004 Oct 15;104(8):2444-51 - PubMed
  7. N Engl J Med. 2004 Apr 8;350(15):1535-48 - PubMed
  8. Genes Chromosomes Cancer. 2004 Sep;41(1):86-91 - PubMed
  9. Blood. 1990 Jan 1;75(1):166-73 - PubMed
  10. Blood. 2007 Apr 15;109(8):3189-97 - PubMed
  11. Curr Opin Genet Dev. 2007 Apr;17(2):157-62 - PubMed
  12. Blood. 2007 Aug 15;110(4):1112-5 - PubMed
  13. J Cell Sci. 2008 Dec 1;121(Pt 23):3859-66 - PubMed
  14. Blood. 2009 Jul 2;114(1):148-52 - PubMed
  15. Hum Mol Genet. 2010 Apr 15;19(8):1507-14 - PubMed
  16. Oncogene. 2010 Apr 29;29(17):2509-16 - PubMed
  17. Cancer Genet Cytogenet. 2010 Feb;197(1):71-4 - PubMed
  18. Cancer Genet Cytogenet. 2010 Jul 1;200(1):8-15 - PubMed
  19. Genes Chromosomes Cancer. 2011 Jan;50(1):51-8 - PubMed
  20. Cancer. 2011 Sep 1;117(17):4009-17 - PubMed
  21. J Biomed Biotechnol. 2011;2011:104631 - PubMed
  22. Int J Hematol. 2012 Dec;96(6):801-5 - PubMed
  23. Leuk Lymphoma. 2014 Feb;55(2):441-3 - PubMed
  24. Blood. 1990 Aug 1;76(3):590-6 - PubMed
  25. Am J Clin Pathol. 2013 Oct;140(4):525-35 - PubMed
  26. Genes Chromosomes Cancer. 2014 Jun;53(6):524-36 - PubMed
  27. Int J Clin Exp Pathol. 2014 Jul 15;7(8):5363-8 - PubMed
  28. Ann Lab Med. 2015 Jan;35(1):128-31 - PubMed
  29. J Assoc Genet Technol. 2014;40(1):11-5 - PubMed
  30. Leuk Res. 2015 Dec;39(12):1414-20 - PubMed
  31. Asian Pac J Cancer Prev. 2015;16(16):7343-50 - PubMed
  32. J Exp Med. 2016 Feb 8;213(2):209-23 - PubMed
  33. Blood. 2017 Jan 26;129(4):424-447 - PubMed
  34. Leuk Res. 2017 Feb;53:20-27 - PubMed
  35. Blood. 1986 Jun;67(6):1688-92 - PubMed
  36. Leukemia. 1994 Jan;8(1):40-5 - PubMed
  37. Blood. 1996 Apr 15;87(8):3135-42 - PubMed
  38. Leukemia. 1996 Jun;10(6):957-63 - PubMed
  39. Cancer Genet Cytogenet. 1996 Nov;92(1):18-23 - PubMed
  40. Leuk Res. 1998 Jul;22(7):581-8 - PubMed

Publication Types